Intraluminal Carotid Artery Thrombus in COVID-19: Another Danger of Cytokine Storm?

References

1. 1.↵
   2. Huang C,
   3. Wang Y,
   4. Li X, et al

   . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506 doi:10.1016/S0140-6736(20)30183-5 pmid:31986264

   CrossRefPubMed
2. 2.↵
   2. Zhou F,
   3. Yu T,
   4. Du R, et al

   . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62 doi:10.1016/S0140-6736(20)30566-3 pmid:32171076

   CrossRefPubMed
3. 3.↵
   2. Madjid M,
   3. Safavi-Naeini P,
   4. Solomon SD, et al

   . Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol 2020 Mar 27. [Epub ahead of print] doi:10.1001/jamacardio.2020 pmid:32219363

   CrossRefPubMed
4. 4.↵
   2. Boehme AK,
   3. Luna J,
   4. Kulick ER, et al

   . Influenza-like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol 2018;5:456–63 doi:10.1002/acn3.545 pmid:29687022

   CrossRefPubMed
5. 5.↵
   American Heart Association. Flu, flu-like illnesses linked to increased risk of stroke, neck artery tears. January 30, 2019. https://www.sciencedaily.com/releases/2019/01/190130075757.htm. Accessed April 6, 2020
6. 6.↵
   2. Rennert RC,
   3. Wali AR,
   4. Steinberg JA, et al

   . Epidemiology, natural history, and clinical presentation of large vessel ischemic stroke. Neurosurgery 2019;85:S4–S8 doi:10.1093/neuros/nyz042 pmid:31197329

   CrossRefPubMed
7. 7.↵
   2. Nighoghossian N,
   3. Derex L,
   4. Douek P

   . The vulnerable carotid artery plaque: current imaging methods and new perspectives. Stroke 2005;36:2764–72 doi:10.1161/01.STR.0000190895.51934.43 pmid:16282537

   Abstract/FREE Full Text
8. 8.↵
   2. Kataoka Y,
   3. Puri R,
   4. Nicholls SJ

   . Inflammation, plaque progression and vulnerability: evidence from intravascular ultrasound imaging. Cardiovasc Diagn Ther 2015;5:280–89 doi:10.3978/j.issn.2223-3652.2015.05.06 pmid:26331112

   CrossRefPubMed
9. 9.↵
   2. Ntaios G,
   3. Wintermark M,
   4. Michel P

   . Supracardiac atherosclerosis in embolic stroke of undetermined source: the underestimated source. Eur Heart J 2020 Apr 16. [Epub ahead of print] doi:10.1093/eurheartj/ehaa218 pmid:32300781

   CrossRefPubMed
10. 10.↵
    2. Kamtchum-Tatuene J,
    3. Wilman A,
    4. Saqqur M, et al

    . Carotid plaque with high-risk features in embolic stroke of undetermined source: systematic review and meta-analysis. Stroke 2020;51:311–14 doi:10.1161/STROKEAHA.119.027272 pmid:31752616

    CrossRefPubMed
11. 11.↵
    2. Villarreal J,
    3. Silva T,
    4. Eliasziw M, et al

    . For the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Prognosis of patients with an intraluminal thrombus in the internal carotid artery. Stroke 1998;29:276
12. 12.↵
    2. Vellimana AK,
    3. Kadkhodayan Y,
    4. Rich KM, et al

    . Symptomatic patients with intraluminal carotid artery thrombus: outcome with a strategy of initial anticoagulation. J Neurosurg 2013;118:34–41 doi:10.3171/2012.9.JNS12406 pmid:23061393

    CrossRefPubMed
13. 13.↵
    2. Simpson S,
    3. Kay FU,
    4. Abbara S, et al

    . Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19: endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. J Thorac Imaging 2020 Apr 28. [Epub ahead of print] doi:10.1097/RTI.0000000000000524 pmid:32324653

    CrossRefPubMed
14. 14.↵
    2. Paoletti R,
    3. Gotto AM Jr.,
    4. Hajjar DP

    . Inflammation in atherosclerosis and implications for therapy. Circulation 2004;109:III20–26 doi:10.1161/01.CIR.0000131514.71167.2e pmid:15198962

    CrossRefPubMed
15. 15.↵
    2. Ridker PM,
    3. Everett BM,
    4. Thuren T, et al

    ; CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017;377:1119–31 doi:10.1056/NEJMoa1707914 pmid:28845751

    CrossRefPubMed
16. 16.↵
    2. Umapathi T,
    3. Kor AC,
    4. Venketasubramanian N, et al

    . Large artery ischaemic stroke in severe acute respiratory syndrome (SARS). J Neurol 2004;251:1227–31 doi:10.1007/s00415-004-0519-8 pmid:15503102

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Arabi YM,
    3. Harthi A,
    4. Hussein J, et al

    . Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection 2015;43:495–501 doi:10.1007/s15010-015-0720-y pmid:25600929

    CrossRefPubMed
18. 18.↵
    2. Keller TT,
    3. Mairuhu AT,
    4. de Kruif MD, et al

    . Infections and endothelial cells. Cardiovasc Res 2003;60:40–48 doi:10.1016/s0008-6363(03)00354-7 pmid:14522405

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Varga Z,
    3. Flammer AJ,
    4. Steiger P, et al

    . Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020;395:1417–18 doi:10.1016/S0140-6736(20)30937-5 pmid:32325026

    CrossRefPubMed